Laura Corbo
Lyon, 69008, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer.
Journal: International journal of molecular sciences
Published: June 29, 2022
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes.
Journal: Breast cancer research and treatment
Published: March 02, 2021
PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor.
Journal: iScience
Published: March 17, 2020
LKB1 regulates PRMT5 activity in breast cancer.
Journal: International journal of cancer
Published: August 27, 2018
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
Journal: Oncogene
Published: July 05, 2018
The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer.
Journal: Oncogene
Published: May 03, 2016
Alternative splicing of CNOT7 diversifies CCR4-NOT functions.
Journal: Nucleic acids research
Published: November 17, 2015
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Journal: Breast cancer research : BCR
Published: October 03, 2014
Proximity ligation assay to detect and localize the interactions of ERα with PI3-K and Src in breast cancer cells and tumor samples.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 04, 2014
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers.
Journal: Molecular oncology
Published: February 04, 2014
Last Updated: 09/26/2026